Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jan Kluytmans"'
Autor:
Ina Willemsen, Jan Kluytmans
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 7, Iss 1, Pp 1-8 (2018)
Antimicrobial Resistance and Infection Control
Antimicrobial Resistance and Infection Control
Background Infection control needs user-friendly standardized instruments to measure the compliance to guidelines and to implement targeted improvement actions. This abstract describes a tool to measure the quality of infection control and antimicrob
Autor:
E.A. Reuland, D. C. Melles, B. Maraha, M Scholing, C.C.H. Wielders, L.J. Bakker, E. I. G. B. de Brauwer, A L M Vlek, S. Groenendijk, S Kuipers, B.C. van Hees, M. van Rijn, Sjoukje H S Woudt, S Erkens-Hulshof, D J Kaersenhout, J.W. Cohen Stuart, J. Alblas, B. M. De Jongh, M.I. van Triest, Jan Kluytmans, B J M Vlaminckx, L. Blijboom, A.G.M. Buiting, W. Silvis, Alexandra T. Bernards, M. van Trijp, J. van Heereveld, J.C. Monen, P H J van Keulen, O. Pontesilli, E.E. Mattsson, I.T.M.A. Overdevest, Marc J. M. Bonten, D.W. van Dam, B.B. Wintermans, E.P.M. van Elzakker, A.J.L. Weersink, Sabine C. de Greeff, T. A. M. Trienekens, J P Arends, H.M.E. Frénay, E. de Jong, G.J.H.M. Ruijs, E.M. Kraan, A. Demeulemeester, Nicole H. M. Renders, Annelot F Schoffelen, D Veenendaal, C M J E Vandenbroucke-Grauls, P. de Man, G A Kampinga, J.W. Dorigo-Zetsma, J.H. van Zeijl, G P Voorn, F.S. Stals, A.J. van Griethuysen, A.L.M. Vlek, R.W. Bosboom, M.A. Leversteijn-van Hall, A. Ott, C.E. Visser, A.E. Muller, Daan W. Notermans, F.N.J. Frakking, M.J.H.M. Wolfhagen, B. Ridwan, W Altorf–van der Kuil, N Vaessen, F.W. Sebens, C Hol, M.H. Nabuurs-Franssen, S. Dinant, B.M.W. Diederen, M.L. van Ogtrop, R. Hertroys, M P D Deege
Publikováno v:
Clinical infectious diseases, 66(11), 1651-1657. Oxford University Press
Clinical Infectious Diseases, 66(11), 1651. Oxford University Press
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases, 66(11), 1651. Oxford University Press
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Antibiotic nonsusceptibility was consistently associated with higher risks of recurrent bacteremia, but the estimated number of additional recurrent episodes in the Netherlands (40 per year) was rather limited.
Background Direct health effects o
Background Direct health effects o
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 25(11)
Objectives We determined the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage upon hospital admission, among patients who were screened preoperatively for nasal S. aureus carriage between 2010 and 2017. We also aimed to
Autor:
Henri A. Verbrugh, Lonneke G. M. Bode, Miranda van Rijen, Heiman F. L. Wertheim, Margreet C. Vos, Christina M. J. E. Vandenbroucke-Grauls, Andreas Voss, Jan Kluytmans, Annet Troelstra
Publikováno v:
Annals of Surgery, 263(3), 511-515. Lippincott Williams & Wilkins
Annals of Surgery, 263(3), 511-515. Lippincott Williams and Wilkins
Annals of Surgery, 263(3), 511. Lippincott Williams and Wilkins
Bode, L G M, van Rijen, M M L, Wertheim, H F L, Vandenbroucke-Grauls, C M J E, Troelstra, A, Voss, A, Verbrugh, H A, Vos, M C & Kluytmans, J A J W 2016, ' Long-term Mortality After Rapid Screening and Decolonization of Staphylococcus Aureus Carriers Observational Follow-up Study of a Randomized, Placebo-controlled Trial ', Annals of Surgery, vol. 263, no. 3, pp. 511-515 . https://doi.org/10.1097/SLA.0000000000001060
Annals of Surgery, 263, 3, pp. 511-5
Annals of Surgery, 263, 511-5
Annals of Surgery, 263(3), 511-515. Lippincott Williams and Wilkins
Annals of Surgery, 263(3), 511. Lippincott Williams and Wilkins
Bode, L G M, van Rijen, M M L, Wertheim, H F L, Vandenbroucke-Grauls, C M J E, Troelstra, A, Voss, A, Verbrugh, H A, Vos, M C & Kluytmans, J A J W 2016, ' Long-term Mortality After Rapid Screening and Decolonization of Staphylococcus Aureus Carriers Observational Follow-up Study of a Randomized, Placebo-controlled Trial ', Annals of Surgery, vol. 263, no. 3, pp. 511-515 . https://doi.org/10.1097/SLA.0000000000001060
Annals of Surgery, 263, 3, pp. 511-5
Annals of Surgery, 263, 511-5
Item does not contain fulltext OBJECTIVE: To identify patients who benefit most from Staphylococcus aureus screening and decolonization treatment upon admission. BACKGROUND: S. aureus carriers are at increased risk of developing surgical-site infecti
Autor:
Nils van ‘t Veer, Marjolein Kluytmans– van den Bergh, Miranda van Rijen, Jan Kluytmans, Pepijn Huizinga, Ina Willemsen
Publikováno v:
Clinical Infectious Diseases, 64(3), 361. Oxford University Press
In this cross-sectional study, 8.5% of patients using proton pump inhibitors (PPIs) were rectal carriers of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E), compared with 2.9% of non-PPI users. In multivariable analysis, PPI use
Autor:
Hasan S. Jafri, Kristin Ohneberg, Karina Olsen, Fleur P Paling, Frangiscos Sifakis, Martin Wolkewitz, Vance G. Fowler, Jan Kluytmans, Mark J. DiNubile, Stéphan Juergen Harbarth, Marc J. M. Bonten
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0193445 (2018)
PLoS ONE [E], 13(3). Public Library of Science
PLOS ONE, Vol. 13, No 3 (2018) P. e0193445
PLoS ONE
PLoS ONE [E], 13(3). Public Library of Science
PLOS ONE, Vol. 13, No 3 (2018) P. e0193445
PLoS ONE
Background Identifying patients undergoing cardiothoracic surgery at high risk of Staphylococcus aureus surgical site infection (SSI) is a prerequisite for implementing effective preventive interventions. The objective of this study was to develop a
Autor:
B.J.M. Vlaminckx, E.M. van de Garde, C.H. van Werkhoven, B.C. van Hees, Wouter C. Rottier, P.D. van der Linden, Annelies Verbon, E.M. Kuck, Y.R.P. Bamberg, H.S.M. Ammerlaan, Jan M. Prins, J.W. Dorigo-Zetsma, Marc J. M. Bonten, Jan Kluytmans, Steven F. T. Thijsen
Publikováno v:
Clinical microbiology and infection, 24(12), 1315-1321. Elsevier Limited
Clinical Microbiology and Infection, 24(12), 1315-1321. Elsevier Ltd.
Clinical Microbiology and Infection, 24(12), 1315-1321. Elsevier Ltd.
Objectives: Current guidelines for the empirical antibiotic treatment predict the presence of third-generation cephalosporin-resistant enterobacterial bacteraemia (3GCR-E-Bac) in case of infection only poorly, thereby increasing unnecessary carbapene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4311d8a05dbd18892398597d3d90185
https://pure.amc.nl/en/publications/development-of-diagnostic-prediction-tools-for-bacteraemia-caused-by-thirdgeneration-cephalosporinresistant-enterobacteria-in-suspected-bacterial-infections-a-nested-casecontrol-study(48730f81-afb2-47ac-9de2-2abc56bd1821).html
https://pure.amc.nl/en/publications/development-of-diagnostic-prediction-tools-for-bacteraemia-caused-by-thirdgeneration-cephalosporinresistant-enterobacteria-in-suspected-bacterial-infections-a-nested-casecontrol-study(48730f81-afb2-47ac-9de2-2abc56bd1821).html
Autor:
Darren P.R. Troeman, Martin Wolkewitz, Daniël R Prins, Surbhi Malhotra-Kumar, Marc J. M. Bonten, Frangiscos Sifakis, Herman Goossens, Jan Kluytmans, Leen Timbermont, Christine Lammens, Susanne Weber, Fleur P Paling, Rubana Kalyani
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-6 (2017)
BMC Infectious Diseases
BMC Infectious Diseases [E], 17(1). BioMed Central
BMC infectious diseases
BMC Infectious Diseases
BMC Infectious Diseases [E], 17(1). BioMed Central
BMC infectious diseases
Background The epidemiology of ICU pneumonia caused by Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa (P. aeruginosa) is not fully described, but is urgently needed to support the development of effective interventions. The objective of
Autor:
Petra J. M. Elders, Jan Kluytmans, Andreas M. Kaiser, N. al Naiemi, Paul H. M. Savelkoul, E. A. Reuland, Max Heck, Christina M. J. E. Vandenbroucke-Grauls
Publikováno v:
Journal of Antimicrobial Chemotherapy, 71(4), 1076-1082. Oxford University Press
Journal of Antimicrobial Chemotherapy
Reuland, E A, Al Naiemi, N, Kaiser, A M, Heck, M, Kluytmans, J A J W, Savelkoul, P H M, Elders, P J M & Vandenbroucke-Grauls, C M J E 2016, ' Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam ', Journal of Antimicrobial Chemotherapy, vol. 71, no. 4, pp. 1076-82 . https://doi.org/10.1093/jac/dkv441
Journal of Antimicrobial Chemotherapy, 71(4), 1076-82. Oxford University Press
Journal of Antimicrobial Chemotherapy, 71(4), 1076. Oxford University Press
Journal of Antimicrobial Chemotherapy
Reuland, E A, Al Naiemi, N, Kaiser, A M, Heck, M, Kluytmans, J A J W, Savelkoul, P H M, Elders, P J M & Vandenbroucke-Grauls, C M J E 2016, ' Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam ', Journal of Antimicrobial Chemotherapy, vol. 71, no. 4, pp. 1076-82 . https://doi.org/10.1093/jac/dkv441
Journal of Antimicrobial Chemotherapy, 71(4), 1076-82. Oxford University Press
Journal of Antimicrobial Chemotherapy, 71(4), 1076. Oxford University Press
OBJECTIVES: The objectives of this study were to determine the prevalence of carriage of ESBL-producing Enterobacteriaceae (ESBL-E) in a representative sample of the general adult Dutch community, to identify risk factors and to gain understanding of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1007afbde711e40d7ddf644709efb428
https://cris.maastrichtuniversity.nl/en/publications/970527d8-8cf9-4baf-a7fb-a3f59eddc262
https://cris.maastrichtuniversity.nl/en/publications/970527d8-8cf9-4baf-a7fb-a3f59eddc262
Autor:
Jan Kluytmans, Patricia Houtman, Ingeborg van Ess, John W. A. Rossen, Dennis Souverein, Sjoerd M. Euser, Jeroen W. Den Boer, Bram M. W. Diederen, Marina van Seventer, Bjorn L. Herpers
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 5, Iss 1, Pp 1-10 (2016)
Antimicrobial Resistance and Infection Control, 5:8. BioMed Central Ltd.
Antimicrobial Resistance and Infection Control, 5. BioMed Central Ltd.
Antimicrobial Resistance and Infection Control
Antimicrobial Resistance and Infection Control, 5:8. BioMed Central Ltd.
Antimicrobial Resistance and Infection Control, 5. BioMed Central Ltd.
Antimicrobial Resistance and Infection Control
This paper describes (1) the Highly Resistant Gram Negative Rod (HR-GNR) prevalence rate, (2) their genotypes, acquired resistance genes and (3) associated risk factors of HR-GNR colonization among the hospitalized population in the Dutch region Kenn